Case report: The effect of second-line vebreltinib treatment on a patient with advanced NSCLC harboring the MET exon 14 skipping mutation after tepotinib treatment

Overview of attention for article published in Frontiers in oncology, April 2024

Altmetric Badge

Mentioned by

reddit: 2 Redditors

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 1 Mendeley

Summary Reddit Dimensions citations

So far, Altmetric has seen 2 Reddit threads by 2 users.

Frontiers | Case report: The effect of second-line vebreltinib treatment on a patient with advanced NSCLC harboring the MET exon 14 skipping mutation after tepotinib treatment

User WalkingHorse, in the LungCancerSupport subreddit, 06 May 2024

Case Report: The Effect of Second-Line Vebreltinib Treatment on a Patient with Advanced NSCLC Harboring the MET Exon 14 Skipping Mutation After Tepotinib Treatment

User montaukwhaler, in the non small cell lung cancer subreddit, 12 Apr 2024

This page shows the most recent Reddit threads that mention this research output.

Click here to find out how to access more activity.